Kappa agonist CovX-BodiesROBERTS, Lee R; BRADY, Kevin; SAUNDERS, Ken et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 12, pp 4173-4178, issn 0960-894X, 6 p.Article

Intein-mediated rapid purification and characterization of a novel recombinant agonist for VPAC2YU, Rong-Jie; XIE, Qiu-Ling; YUN DAI et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 6, pp 1359-1366, issn 0196-9781, 8 p.Article

Morphine et morphiniques. Introduction = Morphine and morphinics. IntroductionTANNIERES-RUFFIE, M.-L; LEVANTE, A.La Revue du praticien (Paris). 1983, Vol 33, Num 7, issn 0035-2640, 277Article

Pharmacologie de la morphine et des morphinomimétiques = Pharmacological study of morphine and morphinomimeticsANDREJAK, M; SCHMITT, H.La Revue du praticien (Paris). 1983, Vol 33, Num 7, pp 279-290, issn 0035-2640Article

Utilisation des morphinomimétiques en milieu chirurgical = Use of morphinomimetics in surgeryFOUILLADIEU, J.-L; TANNIERES-RUFFIE, M.-L; SAMII, K et al.La Revue du praticien (Paris). 1983, Vol 33, Num 7, pp 331-341, issn 0035-2640Article

A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypesSAKAMOTO, Junichi; KIMURA, Hiroyuki; MORIYAMA, Shinji et al.European journal of pharmacology. 2004, Vol 495, Num 1, pp 17-26, issn 0014-2999, 10 p.Article

Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptorsSTRANGE, P. G.British journal of pharmacology. 2008, Vol 153, Num 7, pp 1353-1363, issn 0007-1188, 11 p.Article

In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligandsCASCIO, M. G; BISOGNO, T; BRIZZI, V et al.British journal of pharmacology. 2006, Vol 149, Num 4, pp 431-440, issn 0007-1188, 10 p.Article

Effect of dithiothreitol on agonist and antagonist actions in frog muscleBLEEHEN, T; CLARK, A. L; HOBBIGER, C. F et al.Journal of pharmacy and pharmacology. 1983, Vol 35, Num 10, pp 660-665, issn 0022-3573Article

The anticonvulsant and proconvulsant effects of α₂-ADRENORECEPTOR agonists are mediated by distinct populations of α_2A-ADRENORECEPTORSSZOT, P; LESTER, M; LAUGHLIN, M. L et al.Neuroscience. 2004, Vol 126, Num 3, pp 795-803, issn 0306-4522, 9 p.Article

Agonist binding to multiple muscarinic receptorsVICKROY, T. W; WATSON, M; YAMAMURA, H. I et al.Federation proceedings. 1984, Vol 43, Num 13, pp 2785-2790, issn 0014-9446Conference Paper

Taking the time to study competitive antagonismWYLLIE, D. J. A; CHEN, P. E.British journal of pharmacology. 2007, Vol 150, Num 5, pp 541-551, issn 0007-1188, 11 p.Article

Interactions between corticosteroids and β₂-agonistsHANCOX, Robert J.Clinical reviews in allergy and immunology. 2006, Vol 31, Num 2-3, pp 231-245, issn 1080-0549, 15 p.Article

Control of antigen presentation with a photoreleasable agonist peptideDEMOND, Andrew L; STARR, Toby; DUSTIN, Michael L et al.Journal of the American Chemical Society. 2006, Vol 128, Num 48, pp 15354-15355, issn 0002-7863, 2 p.Article

Simple method for evaluation of stimulatory effect of drugs on presynaptic dopamine receptors in miceWATANABE, H.Journal of pharmacological methods. 1985, Vol 14, Num 1, pp 41-47, issn 0160-5402Article

Minireview two dopamine receptors: biochemistry, physiology and pharmacologySTOOF, J. C; KEBABIAN, J. W.Life sciences (1973). 1984, Vol 35, Num 23, pp 2281-2296, issn 0024-3205Article

Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonistsNEGUS, S. Steuens.Biochemical pharmacology. 2006, Vol 71, Num 12, pp 1663-1670, issn 0006-2952, 8 p.Article

GLUCOCORTICOID HEDGEHOG AGONISTS IN NEUROGENESISJIANGBO WANG; BARAK, Larry S; MOOK, Robert A et al.Vitamins and hormones. 2011, Vol 87, pp 207-215, issn 0083-6729, 9 p.Article

Differential behavioral effect of the TRPM8/TRPA channel agonist icilin (AG-3-5)RAWLS, Scott M; GOMEZ, Teresa; ZHE DING et al.European journal of pharmacology. 2007, Vol 575, Num 1-3, pp 103-104, issn 0014-2999, 2 p.Article

The metabolism of dopamine, NN-dialkylated dopamines and derivatives of the dopamine agonist 2-amino-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) by catechol-O-methyltransferaseYOUDE, I. R; RAXWORTHY, M. J; GULLIVER, P. A et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 5, pp 309-313, issn 0022-3573Article

Sleeping times evoked by alpha adrenoreceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoreceptorsROACH, A. G; DOKEY, J. C; STRACHAN, D. A et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 227, Num 2, pp 421-428, issn 0022-3565Article

Production of paradoxical sensory hypersensitivity by α₂-Adrenoreceptor agonistsQUARTILHO, Aline; MATA, Heriberto P; IBRAHIM, Mohab M et al.Anesthesiology (Philadelphia). 2004, Vol 100, Num 6, pp 1538-1544, issn 0003-3022, 7 p.Article

Inverse agonist activity of agouti and agouti-related proteinCHAI, Biao-Xin; NEUBIG, Richard R; MILLHAUSER, Glenn L et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 4, pp 603-609, issn 0196-9781, 7 p.Article

The dopamine D₂ partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedulesDENGKE ZHANG; XUYI WANG; XIAOJUN XIANG et al.Pharmacology, biochemistry and behavior. 2010, Vol 97, Num 2, pp 222-226, issn 0091-3057, 5 p.Article

Drug efficact and drug resistance : Drug efficact and drug resistanceBAO TING ZHU.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 3, pp 76-89, issn 0753-3322, 14 p.Article